It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Rational Pharmacotherapy in CardiologyAntithrombotic therapy in atrial fibrillation: recent approaches and near perspectives

Antithrombotic therapy in atrial fibrillation: recent approaches and near perspectives

Ya.P. Dovgalevskiy, L.E. Kuvshinova*, I.V. Graifer, N.V. Furman, P.Ya. Dovgalevskiy

Saratov Research Institute for Cardiology. Chernyshevskogo ul. 141, Saratov, 410028 Russia

Recent data and perspectives of antithrombotic therapy in patients with atrial fibrillation (AF) are highlighted. The main statements of current Russian and international guidelines about thromboembolic events prevention in AF patients are presented. Special attention paid to new agents for oral anticoagulation therapy, last information about their efficacy, safety and potential of application.

Key words: atrial fibrillation, antithrombotic therapy, oral anticoagulants, dabigatran, rivaroxaban, apixaban.

Rational Pharmacother. Card. 2011;7(5):628-636

*Corresponding author: l.e.kuvshinova@gmail.ru

Download free full text (PDF)

© 2007 — 2014 «Rational Pharmacotherapy in Cardiology»
«Stolichnaya Izdatelskaya Kompaniya»

ISSN 1819-6446(Print) ISSN 2225-3653 (Online)